entertainment -WSS

entertainment

author：entertainment 2025-09-27 22:49:15 - browse：324

A handout illustration representing Google’s DeepMind subsidiary and Isomorphic Labs developed an AI model that can accurately predict how a vast universe of biomolecules interact on an atomic level. — DeepMind

Google on Wednesday unveiled an artificial intelligence tool capable of predicting the structure and interaction of a vast universe of biomolecules, a fundamental advance that may help scientists unravel poorly understood aspects of biology and disease.

The new AI, dubbed AlphaFold 3, improves upon earlier versions of the model by predicting not just the structure of proteins, but all the molecules that interact with them in cells, including RNA, DNA, ions, and other small molecules.

Most new drugs consist of small molecules designed to bind to a protein involved in disease. AlphaFold 3 opens broader avenues of exploration, allowing scientists to rapidly examine complex interactions with other molecules that may highlight new disease targets — and different ways of attacking them.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Vaccine advisory panel ACIP left half staffed by HHS

WSS

Private equity deals in Medicare Advantage declines

Biogen Alzheimer’s drug launch off to slow start

Medicare threatens to cut off funding for HCA's Mission hospital

Elon Musk says Twitter has 'negative cash flow' and 'heavy debt'

Vaccine advisory panel ACIP left half staffed by HHS

Readout Newsletter: Biogen, Rocket Pharma, KalVista, and more

knowledge

entertainment

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Blood tests recalled over risk of missed heart attack diagnosis

Hollywood unions extend contract negotiations for actors

Eli Lilly to acquire Versanis in heated race for weight loss drugs

What does generative AI mean for health care? We asked experts

Federal judge rules Oregon’s tough new gun law is constitutional

Wildfire smoke exposes gaps in outdoor worker protections

Mike Pence clashes with Tucker Carlson in Iowa

Hepatitis C has a cure — but many Americans still lack access to it

Biden report: The neurospychology of memory and aging

explore

Senators start work on Medicare physician payment reform

Special counsel informs Trump he is target in probe of efforts to overturn 2020 election

Europe sees delivery challenges ahead on Alzheimer's therapies

Involuntary treatment for addiction doesn't work

Congress likely to miss an opportunity to fix drug shortages issue

Why police arrested suspected Gilgo Beach killer away from his house

hotspot

knowledge

knowledge

hotspot